Kidswell Bio Corporation (TYO:4584)

Kidswell Bio Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2025	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Net Income	72	-533	-999	-7,314	-856.29
Depreciation & Amortization	-	2	-	-	0.32
Loss (Gain) From Sale of Assets	6	-	1	5,982	-
Asset Writedown & Restructuring Costs	-	-	-	-	0.4
Loss (Gain) From Sale of Investments	-35	-417	7	-4	-
Other Operating Activities	-5	-1	-2	-3	2.25
Change in Accounts Receivable	-385	354	-174	-89	-154.31
Change in Inventory	-599	-538	-196	-101	-11.93
Change in Accounts Payable	56	-171	265	-207	-3.39
Change in Other Net Operating Assets	1,826	135	-169	411	162.65
Operating Cash Flow	936	-1,169	-1,267	-1,325	-860.32
Capital Expenditures	-6	-	-	-1	-
Cash Acquisitions	-	-	-	12	-
Divestitures	-	-	-14	-	-
Sale (Purchase) of Intangibles	-	-	-3	-	-
Investment in Securities	74	526	-	-94	-
Other Investing Activities	-3	-	-5	-4	-0.03
Investing Cash Flow	65	526	-22	-137	-0.03
Long-Term Debt Issued	-	-	599	1,181	-
Total Debt Issued	-	-	599	1,181	-
Short-Term Debt Repaid	-	-	-25	-	-
Long-Term Debt Repaid	-748	-	-	-	-
Total Debt Repaid	-748	-	-25	-	-
Net Debt Issued (Repaid)	-748	-	574	1,181	-
Issuance of Common Stock	508	369	143	43	973.09
Other Financing Activities	-	-	1	-3	5.35
Financing Cash Flow	-240	369	718	1,221	978.45
Foreign Exchange Rate Adjustments	2	-	-	-	-
Miscellaneous Cash Flow Adjustments	1	1	-	264	-0
Net Cash Flow	764	-273	-571	23	118.1
Free Cash Flow	930	-1,169	-1,267	-1,326	-860.32
Free Cash Flow Margin	18.30%	-74.51%	-127.21%	-123.12%	-84.20%
Free Cash Flow Per Share	22.96	-37.89	-44.01	-47.97	-44.05
Cash Interest Paid	46	15	15	5	-
Cash Income Tax Paid	1	1	2	2	1.9
Levered Free Cash Flow	-	-895.75	-954.63	-753.19	-519
Unlevered Free Cash Flow	-	-886.38	-945.25	-750.06	-519
Change in Working Capital	898	-220	-274	14	-6.99

Source: S&P Global Market Intelligence. Standard template. Financial Sources.